Aligos Therapeutics Inc.

NASDAQ: ALGS · Real-Time Price · USD
7.70
0.12 (1.52%)
At close: Aug 15, 2025, 3:59 PM
7.70
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Aligos Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.9 -4.71 -10.59 -92.16
PEG Ratio
-0.00 -0.08 0.35 -73.27
PS Ratio
63.27 26.59 73.13 2.71K
PB Ratio
-8.61 4.48 9.79 64.02
P/FCF Ratio
-3.09 -5.23 -12.66 -101.47
P/OCF Ratio
-3.09 -5.23 -12.81 -102.26
OCF/S Ratio
-20.47 -5.09 -5.71 -26.53
Debt / Equity Ratio
-0.29 0.12 0.12 0.08
Quick Ratio
2.86 5.90 4.03 5.25
Current Ratio
2.86 5.90 4.03 5.25
Asset Turnover
0.06 0.10 0.09 0.02
Interest Coverage
n/a n/a -59.5 -972.13
Return on Equity
4.53 -0.95 -0.92 -0.69
Return on Assets
-1.87 -0.58 -0.65 -0.55
Return on Invested Capital
-1.72 -0.66 -0.82 -0.64
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 0.80 0.74 -22.89
Net Profit Margin
-33.26 -5.65 -6.91 -29.44
Pretax Profit Margin
-33.18 -5.59 -6.9 -29.41
Operating Profit Margin
-22.6 -5.67 -7.02 -29.44
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-22.6 -5.48 -6.75 -28.57